Heat Shock protein 90: Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy

Yueh Liang Tsou, Yi Wen Lin, Hsuen Wen Chang, Hsiang Yin Lin, Hsiao Yun Shao, Shu Ling Yu, Chia Chyi Liu, Ebenezer Chitra, Charles Sia, Yen Hung Chow

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Although several factors participating in enterovirus 71 (EV71) entry and replication had been reported, the precise mechanisms associated with these events are far from clear. In the present study, we showed that heat shock protein 90 (HSP90) is a key element associated with EV71 entry and replication in a human rhabdomyosarcoma of RD cells. Inhibition of HSP90 by pretreating host cells with HSP90β siRNA or blocking HSP90 with a HSP90-specific antibody or geldanamycin (GA), a specific inhibitor of HSP90, as well as recombinant HSP90β resulted in inhibiting viral entry and subsequent viral replication. Co-immunprecipitation of EV71 with recombinant HSP90β and colocalization of EV71-HSP90 in the cells demonstrated that HSP90 was physically associated with EV71 particles. HSP90 seems to mediate EV71 replication by preventing proteosomal degradation of the newly synthesized capsid proteins, but does not facilitate viral gene expression at transcriptional level. This was evident by post-treatment of host cells with GA, which did not affect the expression of viral transcripts but accelerated the degradation of viral capsid proteins and interfered with the formation of assembled virions. In vivo studies were carried out using human SCARB2-transgenic mice to evaluate the protection conferred by HSP90 inhibitor, 17-allyamino-17-demethoxygeldanamycin (17-AAG), an analog of geldanamycin, that elicited similar activity but with less toxicity. The results showed that the administration of 17-AAG twice conferred the resistance to hSCARB2 mice challenged with C2, C4, and B4 genotypes of EV71. Our data supports HSP90 plays an important role in EV71 infection. Targeting of HSP90 with clinically available drugs might provide a feasible therapeutic approach to treat EV71 infection.

Original languageEnglish
Article numbere77133
JournalPLoS One
Volume8
Issue number10
DOIs
Publication statusPublished - Oct 2 2013
Externally publishedYes

Fingerprint

HSP90 Heat-Shock Proteins
Enterovirus
therapeutics
Therapeutics
Enterovirus Infections
Capsid Proteins
heat-shock protein 90
coat proteins
Recombinant Proteins
recombinant proteins
cells
Degradation
degradation
Viral Genes
Rhabdomyosarcoma
viral proteins
mice
Viral Proteins
virus replication
small interfering RNA

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Heat Shock protein 90 : Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy. / Tsou, Yueh Liang; Lin, Yi Wen; Chang, Hsuen Wen; Lin, Hsiang Yin; Shao, Hsiao Yun; Yu, Shu Ling; Liu, Chia Chyi; Chitra, Ebenezer; Sia, Charles; Chow, Yen Hung.

In: PLoS One, Vol. 8, No. 10, e77133, 02.10.2013.

Research output: Contribution to journalArticle

Tsou, YL, Lin, YW, Chang, HW, Lin, HY, Shao, HY, Yu, SL, Liu, CC, Chitra, E, Sia, C & Chow, YH 2013, 'Heat Shock protein 90: Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy', PLoS One, vol. 8, no. 10, e77133. https://doi.org/10.1371/journal.pone.0077133
Tsou, Yueh Liang ; Lin, Yi Wen ; Chang, Hsuen Wen ; Lin, Hsiang Yin ; Shao, Hsiao Yun ; Yu, Shu Ling ; Liu, Chia Chyi ; Chitra, Ebenezer ; Sia, Charles ; Chow, Yen Hung. / Heat Shock protein 90 : Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy. In: PLoS One. 2013 ; Vol. 8, No. 10.
@article{e8f7550affdf490ab4d7f98bc584a2f3,
title = "Heat Shock protein 90: Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy",
abstract = "Although several factors participating in enterovirus 71 (EV71) entry and replication had been reported, the precise mechanisms associated with these events are far from clear. In the present study, we showed that heat shock protein 90 (HSP90) is a key element associated with EV71 entry and replication in a human rhabdomyosarcoma of RD cells. Inhibition of HSP90 by pretreating host cells with HSP90β siRNA or blocking HSP90 with a HSP90-specific antibody or geldanamycin (GA), a specific inhibitor of HSP90, as well as recombinant HSP90β resulted in inhibiting viral entry and subsequent viral replication. Co-immunprecipitation of EV71 with recombinant HSP90β and colocalization of EV71-HSP90 in the cells demonstrated that HSP90 was physically associated with EV71 particles. HSP90 seems to mediate EV71 replication by preventing proteosomal degradation of the newly synthesized capsid proteins, but does not facilitate viral gene expression at transcriptional level. This was evident by post-treatment of host cells with GA, which did not affect the expression of viral transcripts but accelerated the degradation of viral capsid proteins and interfered with the formation of assembled virions. In vivo studies were carried out using human SCARB2-transgenic mice to evaluate the protection conferred by HSP90 inhibitor, 17-allyamino-17-demethoxygeldanamycin (17-AAG), an analog of geldanamycin, that elicited similar activity but with less toxicity. The results showed that the administration of 17-AAG twice conferred the resistance to hSCARB2 mice challenged with C2, C4, and B4 genotypes of EV71. Our data supports HSP90 plays an important role in EV71 infection. Targeting of HSP90 with clinically available drugs might provide a feasible therapeutic approach to treat EV71 infection.",
author = "Tsou, {Yueh Liang} and Lin, {Yi Wen} and Chang, {Hsuen Wen} and Lin, {Hsiang Yin} and Shao, {Hsiao Yun} and Yu, {Shu Ling} and Liu, {Chia Chyi} and Ebenezer Chitra and Charles Sia and Chow, {Yen Hung}",
year = "2013",
month = "10",
day = "2",
doi = "10.1371/journal.pone.0077133",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Heat Shock protein 90

T2 - Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy

AU - Tsou, Yueh Liang

AU - Lin, Yi Wen

AU - Chang, Hsuen Wen

AU - Lin, Hsiang Yin

AU - Shao, Hsiao Yun

AU - Yu, Shu Ling

AU - Liu, Chia Chyi

AU - Chitra, Ebenezer

AU - Sia, Charles

AU - Chow, Yen Hung

PY - 2013/10/2

Y1 - 2013/10/2

N2 - Although several factors participating in enterovirus 71 (EV71) entry and replication had been reported, the precise mechanisms associated with these events are far from clear. In the present study, we showed that heat shock protein 90 (HSP90) is a key element associated with EV71 entry and replication in a human rhabdomyosarcoma of RD cells. Inhibition of HSP90 by pretreating host cells with HSP90β siRNA or blocking HSP90 with a HSP90-specific antibody or geldanamycin (GA), a specific inhibitor of HSP90, as well as recombinant HSP90β resulted in inhibiting viral entry and subsequent viral replication. Co-immunprecipitation of EV71 with recombinant HSP90β and colocalization of EV71-HSP90 in the cells demonstrated that HSP90 was physically associated with EV71 particles. HSP90 seems to mediate EV71 replication by preventing proteosomal degradation of the newly synthesized capsid proteins, but does not facilitate viral gene expression at transcriptional level. This was evident by post-treatment of host cells with GA, which did not affect the expression of viral transcripts but accelerated the degradation of viral capsid proteins and interfered with the formation of assembled virions. In vivo studies were carried out using human SCARB2-transgenic mice to evaluate the protection conferred by HSP90 inhibitor, 17-allyamino-17-demethoxygeldanamycin (17-AAG), an analog of geldanamycin, that elicited similar activity but with less toxicity. The results showed that the administration of 17-AAG twice conferred the resistance to hSCARB2 mice challenged with C2, C4, and B4 genotypes of EV71. Our data supports HSP90 plays an important role in EV71 infection. Targeting of HSP90 with clinically available drugs might provide a feasible therapeutic approach to treat EV71 infection.

AB - Although several factors participating in enterovirus 71 (EV71) entry and replication had been reported, the precise mechanisms associated with these events are far from clear. In the present study, we showed that heat shock protein 90 (HSP90) is a key element associated with EV71 entry and replication in a human rhabdomyosarcoma of RD cells. Inhibition of HSP90 by pretreating host cells with HSP90β siRNA or blocking HSP90 with a HSP90-specific antibody or geldanamycin (GA), a specific inhibitor of HSP90, as well as recombinant HSP90β resulted in inhibiting viral entry and subsequent viral replication. Co-immunprecipitation of EV71 with recombinant HSP90β and colocalization of EV71-HSP90 in the cells demonstrated that HSP90 was physically associated with EV71 particles. HSP90 seems to mediate EV71 replication by preventing proteosomal degradation of the newly synthesized capsid proteins, but does not facilitate viral gene expression at transcriptional level. This was evident by post-treatment of host cells with GA, which did not affect the expression of viral transcripts but accelerated the degradation of viral capsid proteins and interfered with the formation of assembled virions. In vivo studies were carried out using human SCARB2-transgenic mice to evaluate the protection conferred by HSP90 inhibitor, 17-allyamino-17-demethoxygeldanamycin (17-AAG), an analog of geldanamycin, that elicited similar activity but with less toxicity. The results showed that the administration of 17-AAG twice conferred the resistance to hSCARB2 mice challenged with C2, C4, and B4 genotypes of EV71. Our data supports HSP90 plays an important role in EV71 infection. Targeting of HSP90 with clinically available drugs might provide a feasible therapeutic approach to treat EV71 infection.

UR - http://www.scopus.com/inward/record.url?scp=84884863066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884863066&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0077133

DO - 10.1371/journal.pone.0077133

M3 - Article

C2 - 24098578

AN - SCOPUS:84884863066

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e77133

ER -